Thymosin alpha-1 enhanced the differentiation of tumor-associated macrophages into dendritic cells with improved antitumor antigen presentation, creating more effective cancer-fighting immune cells from the tumor's own immune infiltrate.
Key findingThymosin alpha-1 promoted differentiation of tumor-associated macrophages into functional dendritic cells with enhanced antigen presentation and antit
What the researchers found
Thymosin alpha-1 promoted differentiation of tumor-associated macrophages into functional dendritic cells with enhanced antigen presentation and antitumor activity — converting tumor immune suppressor cells into effective cancer fighters.
Why it matters
Relevant for thymosin-alpha-1, cancer, immune-function.
How the study worked
animal-study study on thymosin-alpha-1, cancer.
What this study cannot tell us
See abstract.
How to read the evidence
preliminary evidence.
When this study was published
Published in 2004.
The bigger picture
Advances peptide therapeutics research.
Questions still open
- Further research needed.
- Clinical translation to evaluate.
Common questions
What was studied?
What was found?
Read the original research
Effect of thymosin alpha 1 on the antitumor activity of tumor-associated macrophage-derived dendritic cells.
Journal of biomedical science, 11(5), 623-30
Citation
Shrivastava, Pratima; Singh, Sukh Mahendra; Singh, Nisha. (2004). Effect of thymosin alpha 1 on the antitumor activity of tumor-associated macrophage-derived dendritic cells.. Journal of biomedical science, 11(5), 623-30.